News

Sorted by: Date | Title

Dana-Farber/Boston Children’s remains nation’s #1 pediatric cancer program

June 21, 2016
U.S. News & World Report has once again ranked Dana-Farber/Boston Children’s Cancer and Blood Disorders Center the nation’s #1 pediatric cancer program in its new 2016-17 Best Children’s Hospitals rankings.

How drug companies use gifts and internships to reach valuable hemophilia patients

June 14, 2016
In a Washington Post story on new research about pharmaceutical companies’ direct outreach to hemophilia patients, Ellis Neufeld, MD, notes: These tactics can “get in the way of the doctor-patient relationship.”

Dual stem-cell transplant improves outlook for children with high-risk neuroblastoma

June 05, 2016
Children with high-risk neuroblastoma whose treatment included two autologous stem-cell transplants were more likely to be free of cancer three years later than patients who underwent a single transplant, according to results of a Phase 3 clinical trial presented at the annual meeting of the American Society of Clinical Oncology. The tandem transplant technique produced even better results when followed by treatment with immunotherapy agents, investigators found.

Science commentary explores ways to pay for success in gene therapy

May 26, 2016
Noting the potential of gene therapy to be a one-time treatment for rare and serious diseases that otherwise cost hundreds of thousands, if not millions, of dollars in chronic care over a lifetime, the authors suggest several models for valuing, pricing and developing gene therapy.

Q & A: Making sense of new research on possible link between phototherapy for newborn jaundice and cancer

May 23, 2016
Two new studies published in the journal Pediatrics analyze large datasets to see if there is a link between phototherapy (light therapy) for newborn jaundice and pediatric cancer. Lindsay Frazier, MD, a pediatric oncologist at Dana-Farber/Boston Children’s, and Anne Hansen, MD, MPH, medical director of the Neonatal Intensive Care Unit at Boston Children’s Hospital, answer questions about the new research and its implications.

Evidence suggesting link between cancer and light therapy for newborn jaundice is inconclusive but warrants consideration

May 23, 2016
Two new studies raise enough questions about a possible link between childhood cancer and light therapy for newborn jaundice that clinicians should exercise caution in prescribing the treatment for infants whose jaundice is likely to resolve on its own.

We’ve known for 50 years what causes sickle cell disease. Where’s the cure?

May 19, 2016
Boston Globe Media’s Stat examines efforts to use gene therapy or gene editing – or develop a pill – to harness the latest research on sickle cell disease. “This is the right time for a sickle cell moonshot,” says Dana-Farber/Boston Children’s President David Williams, MD.

Genetic treatments for sickle cell

May 01, 2016
Researchers at Dana-Farber/Boston Children's and other centers are focusing on controlling the switch that regulates hemoglobin production to prevent the devastation of sickle cell disease, Scientific American reports.

Brave boy donates bone marrow to sister fighting leukemia

April 28, 2016
When his 3-year-old sister needed a stem cell transplant for relapsed leukemia, her 5-year-old brother was a perfect match. So he bravely had his stem cells surgically harvested to save his sister, WBZ-TV reports.

Young adult survivors of childhood cancer report overall health similar to middle-aged in general population

April 21, 2016
Do survivors of childhood cancer return to normal health as they grow up? According to new research published in the Journal of the National Cancer Institute, overall health-related quality of life in young adult survivors of childhood cancer resembles that of middle-aged adults.
Showing 1-10 of 152 items